Delivery Order SPE2DB20D9329-SPE2DB25FZK92
- Not listed
- The U.S. Defense Logistics Agency issued a delivery order valued at $67,919.25 to DMS Pharmaceutical Group Inc. for the supply of Botox 200 Unit Vials with an ultimate completion date of October 6, 2025. This firm fixed-price delivery order was awarded on September 15, 2025, without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this work at its Park Ridge facility. The award represents...
- The Defense Logistics Agency awarded a $4,625.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Botox 100 unit vials, with an ultimate completion date of October 17, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, valued at $500 million and...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,937.00 to DMS Pharmaceutical Group Inc. for the supply of Botox 200 unit vials. The contract, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, represents a standard procurement with no set-aside designation. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery from its Illinois location. This...
- The Defense Logistics Agency awarded a $12,937 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 200-unit vials of Botox. The delivery order, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, carries no set-aside designation. This award represents a discrete delivery under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,312.85 to DMS Pharmaceutical Group Inc. for the supply of Botox 100 unit vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order carries an ultimate completion date of September 24, 2025, and represents a specific fulfillment under the company's broader procurement...
- The Defense Logistics Agency awarded a delivery order valued at $15,524.40 to DMS Pharmaceutical Group Inc. for the supply of Botox 200 Unit Vials. The contract was awarded on September 24, 2025, with an ultimate completion date of October 16, 2025, and operates under firm fixed-price terms. This delivery order was issued without a set-aside designation and will be performed at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $9,251.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100-unit vials. The award was issued on September 15, 2025, with an ultimate completion date of October 6, 2025, and represents a competitive procurement without set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $6,468.50 to DMS Pharmaceutical Group Inc. on September 16, 2025, for the supply of 200-unit vials of Botox. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform delivery at its facility in Park Ridge. The contract is structured as a firm fixed-price delivery order with no set-aside designation, and is scheduled for completion by October 7, 2025. This award...
- The Defense Logistics Agency awarded a delivery order valued at $11,101.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 Unit Vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and carries no set-aside designation. This award represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on September 29, 2025, for the supply of Botox 200 unit vials valued at $7,115.35. This firm fixed-price delivery order represents a single procurement issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA, valued at $499,999,999 and extending through November 2026. The order is set to complete by October 21, 2025, with fulfillment occurring from the vendor's Park Ridge, Illinois...
- SPE2DB20D9329Indefinite Delivery Contract
- SPE2DB20D9329-SPE2DB25FZK92Delivery Order
The Defense Logistics Agency awarded a $64,685 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for the supply of Botox 200 unit vials. The award, issued on August 26, 2025, with an ultimate completion date of September 17, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge facility. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products to support military health facilities worldwide. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has established a robust portfolio of federal contract awards encompassing an extensive array of medical products including prescription medications, biologics, and specialty pharmaceutical items. The company's experience supplying Botox and other specialized medications to Department of Defense healthcare sites demonstrates its capability to provide high-quality pharmaceutical products essential for military medical operations. This delivery order represents one of multiple pharmaceutical product acquisitions the Defense Logistics Agency facilitates through its relationship with DMS Pharmaceutical Group to ensure consistent availability of critical medical supplies across the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $64.7k | 8/26/25 |